Author: Zhang, Ke; Miorin, Lisa; Makio, Tadashi; Dehghan, Ishmael; Gao, Shengyan; Xie, Yihu; Zhong, Hualin; Esparza, Matthew; Kehrer, Thomas; Kumar, Anil; Hobman, Tom C.; Ptak, Christopher; Gao, Boning; Minna, John D.; Chen, Zhijian; GarcÃa-Sastre, Adolfo; Ren, Yi; Wozniak, Richard W.; Fontoura, Beatriz M.A.
Title: Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression Cord-id: 0lterjmt Document date: 2021_2_5
ID: 0lterjmt
Snippet: The ongoing unprecedented severe acute respiratory syndrome caused by the SARS-CoV-2 outbreak worldwide has highlighted the need for understanding viral-host interactions involved in mechanisms of virulence. Here, we show that the virulence factor Nsp1 protein of SARS-CoV-2 interacts with the host messenger RNA (mRNA) export receptor heterodimer NXF1-NXT1, which is responsible for nuclear export of cellular mRNAs. Nsp1 prevents proper binding of NXF1 to mRNA export adaptors and NXF1 docking at t
Document: The ongoing unprecedented severe acute respiratory syndrome caused by the SARS-CoV-2 outbreak worldwide has highlighted the need for understanding viral-host interactions involved in mechanisms of virulence. Here, we show that the virulence factor Nsp1 protein of SARS-CoV-2 interacts with the host messenger RNA (mRNA) export receptor heterodimer NXF1-NXT1, which is responsible for nuclear export of cellular mRNAs. Nsp1 prevents proper binding of NXF1 to mRNA export adaptors and NXF1 docking at the nuclear pore complex. As a result, a significant number of cellular mRNAs are retained in the nucleus during infection. Increased levels of NXF1 rescues the Nsp1-mediated mRNA export block and inhibits SARS-CoV-2 infection. Thus, antagonizing the Nsp1 inhibitory function on mRNA export may represent a strategy to restoring proper antiviral host gene expression in infected cells.
Search related documents:
Co phrase search for related documents- abcam dilution and mab monoclonal antibody: 1
- absence presence and action mechanism: 1, 2, 3, 4, 5, 6
- absence presence and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- absence presence and low concentration: 1, 2, 3
- absence presence and lysis buffer: 1, 2, 3, 4, 5
- absence presence and mab monoclonal antibody: 1
- absence presence and magnetic bead: 1, 2, 3
- action mechanism and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- action mechanism and adaptor protein: 1
- action mechanism and low concentration: 1, 2, 3, 4
- action mechanism and mab monoclonal antibody: 1, 2, 3, 4
- acute sars cov respiratory syndrome coronavirus and adaptor protein: 1, 2, 3, 4
- acute sars cov respiratory syndrome coronavirus and low concentration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute sars cov respiratory syndrome coronavirus and lysis buffer: 1, 2, 3
- acute sars cov respiratory syndrome coronavirus and mab monoclonal antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute sars cov respiratory syndrome coronavirus and magnetic bead: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- adaptor protein and lrr leucine rich repeat: 1
- low concentration and lysis buffer: 1, 2
- low concentration and mab monoclonal antibody: 1
Co phrase search for related documents, hyperlinks ordered by date